Page 10 - TD-4-2
P. 10

Tumor Discovery                                                                   AI in cancer research



            of the disease. AI-powered imaging tools, particularly   proteins crucial to cancer development. By targeting these
            convolutional neural networks, excel at detecting patterns   molecules, researchers can design therapies with a higher
            in medical images. They can identify tumors, classify their   likelihood of success. In addition, AI facilitates drug
            types, and even predict their aggressiveness. These tools   repurposing, a process in which new uses for existing drugs
            often  outperform  human  radiologists  in  certain  tasks,   are identified. This approach saves time and resources, as
            offering consistent and rapid analyses.            these drugs have already passed safety tests.
              For example, in histopathology, AI algorithms analyze   2. Future challenges and ethical
            tissue samples to detect cancer cells.  They identify   considerations
                                             7
            morphological patterns that may escape the human
            eye, increasing diagnostic accuracy. This capability is   Despite its transformative potential, the application of AI
            especially valuable in early detection, where timely   in cancer research is not without its challenges. A primary
            intervention can significantly improve patient outcomes.   concern is data quality. Although AI can process large data
            The role of AI in drug discovery is another paradigm   sets, the conclusions it draws are only as reliable as the
            shift for cancer research.  Traditional drug development   data it analyzes. Ensuring high-quality and representative
                                8
            is notoriously slow and expensive, often taking more than   data sets is critical to avoid biased or misleading results.
            a decade from discovery to approval. AI streamlines this   Another challenge lies in interpretability. Many AI models,
            process by identifying promising drug candidates more   particularly deep learning systems, operate as “black boxes,”
            quickly. Through the analysis of biological pathways and   producing results without offering clear explanations about
            protein interactions, AI algorithms highlight genes and   how they were derived. This lack of transparency can hinder















































            Figure 1. Imaginative representation of artificial intelligence in cancer research, showing the superimposition of a binary text in a background of a picture
            of tumor cells.

            Volume 4 Issue 2 (2025)                         2                            doi: 10.36922/TD025040006
   5   6   7   8   9   10   11   12   13   14   15